Boston Scientific unlikely to meet 2026 sales and profit forecasts after cyberattack
Boston Scientific said it is unlikely to meet its 2026 sales and profit forecasts following a cyberattack. The medical device manufacturer did not disclose additional details about the scope or timing of the attack.

Reported from
Start the conversation
Nobody has said anything yet. No account, no email — a name is optional.
Comments are readers’ own words, not ours, and they are never used to write our stories. What we keep



